ERPRF yields 9.42% · JNJ yields 2.14%● Live data
📍 ERPRF pulled ahead of the other in Year 1
Combined, ERPRF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ERPRF + JNJ for your $10,000?
European Reliance General Insurance Company S.A., together with its subsidiaries, provides various insurance products and services to individuals and businesses in Greece. The company offers income protection, medical expenses, family, child, motor, home, health, and quality life insurances, as well as pension programs. It also provides business insurance programs, such as building coverage, group, cargo, and third party liability insurance programs; and financial loss programs that cover loss of income, loss of profits, loss of wages, and operating expenses. In addition, the company offers facility management services; mutual fund management services, including portfolio management, corporate finance, and venture capital; investment services; and housekeeping services. Further, it acts as an insurance broker; and produces electricity through photovoltaic power stations. The company offers products and services through a network of sales persons, as well as through online. European Reliance General Insurance Company S.A. was founded in 1977 and is headquartered in Chalandri, Greece.
Full ERPRF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.